89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,009,851 | +12.9% | 1,619,809 | +38.5% | 0.01% | +25.0% |
| Q2 2023 | $22,157,401 | -33.2% | 1,169,256 | -46.3% | 0.00% | -42.9% |
| Q1 2023 | $33,188,531 | +156.0% | 2,179,155 | +114.0% | 0.01% | +133.3% |
| Q4 2022 | $12,961,839 | +79.1% | 1,018,212 | -18.5% | 0.00% | +200.0% |
| Q3 2022 | $7,236,000 | +105.2% | 1,249,822 | +14.1% | 0.00% | 0.0% |
| Q2 2022 | $3,526,000 | +120.2% | 1,095,204 | +158.0% | 0.00% | – |
| Q1 2022 | $1,601,000 | -54.7% | 424,519 | +57.0% | 0.00% | -100.0% |
| Q4 2021 | $3,534,000 | -37.8% | 270,404 | -6.7% | 0.00% | 0.0% |
| Q3 2021 | $5,678,000 | -37.9% | 289,854 | -40.7% | 0.00% | -50.0% |
| Q2 2021 | $9,140,000 | -25.4% | 488,765 | -5.5% | 0.00% | -33.3% |
| Q1 2021 | $12,253,000 | +2.6% | 517,467 | +5.6% | 0.00% | 0.0% |
| Q4 2020 | $11,940,000 | +4833.9% | 489,953 | +5093.5% | 0.00% | – |
| Q3 2020 | $242,000 | – | 9,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |